About us

About us

Milla Pharmaceuticals Inc., an A.forall company

Milla Pharmaceuticals Inc. is a pharmaceutical company with over a 100 years of collective experience in the US pharmaceutical industry with headquarters in White Bear Lake, Minnesota and team members across the US.

 

With headquarters in Belgium and offices in Ireland and the US, we represent 144 employees spread over 17 different countries.

Making Affordable Medicines Available To All

We develop value-added injectables, address product shortages, and fill unmet medical needs for patients to continue their treatment.

Milla Pharmaceuticals, an A.forall company strives to provide exceptional service to ensure supply to patients in the US.

Our Numbers

6

ANDAs approved since 2021

3

First cycle ANDA Approvals

11% of applicants achieve a First Cycle Approval

2

Paragraph IV Approvals

2

Competitive Generic Therapy Exclusivities Granted

Our History

2020
Launch of Acetaminophen IV Injection.
2021
Launch of Sodium Acetate 2mEq Injection.
2023
Launch of Pyridostigmine Oral Solution.
2023
Launch of Magnesium Sulfate in Water Injection.
2024
Launch of Dexmedetomidine Injection.
2025
Launch of Tromethamine Injection under our own label.
2025
Launch of Sodium Acetate 2mEq Injection under our own label.

Follow us on LinkedIn

Keep up to date with A.forall by following us on LinkedIn.

We regulary post our lastest updates, product launches, partnerships and employee stories.

Let's connect now